- Home
- KZR vs IMRX Comparison
KZR vs IMRX Comparison
Compare KZR & IMRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KZR
- IMRX
- Stock Information
- Founded
- KZR 2015
- IMRX 2008
- Country
- KZR United States
- IMRX United States
- Employees
- KZR N/A
- IMRX N/A
- Industry
- KZR Biotechnology: Pharmaceutical Preparations
- IMRX Biotechnology: Pharmaceutical Preparations
- Sector
- KZR Health Care
- IMRX Health Care
- Exchange
- KZR Nasdaq
- IMRX Nasdaq
- Market Cap
- KZR 65.3M
- IMRX 73.2M
- IPO Year
- KZR 2018
- IMRX 2021
- Fundamental
- Price
- KZR $7.53
- IMRX $1.80
- Analyst Decision
- KZR Hold
- IMRX Buy
- Analyst Count
- KZR 2
- IMRX 7
- Target Price
- KZR $11.00
- IMRX $12.60
- AVG Volume (30 Days)
- KZR 61.7K
- IMRX 349.0K
- Earning Date
- KZR 11-12-2024
- IMRX 11-13-2024
- Dividend Yield
- KZR N/A
- IMRX N/A
- EPS Growth
- KZR N/A
- IMRX N/A
- EPS
- KZR N/A
- IMRX N/A
- Revenue
- KZR N/A
- IMRX N/A
- Revenue This Year
- KZR N/A
- IMRX N/A
- Revenue Next Year
- KZR $66.68
- IMRX N/A
- P/E Ratio
- KZR N/A
- IMRX N/A
- Revenue Growth
- KZR N/A
- IMRX N/A
- 52 Week Low
- KZR $5.20
- IMRX $1.00
- 52 Week High
- KZR $11.40
- IMRX $8.89
- Technical
- Relative Strength Index (RSI)
- KZR 49.59
- IMRX 42.88
- Support Level
- KZR $7.27
- IMRX $1.68
- Resistance Level
- KZR $7.50
- IMRX $2.17
- Average True Range (ATR)
- KZR 0.48
- IMRX 0.14
- MACD
- KZR -0.08
- IMRX -0.01
- Stochastic Oscillator
- KZR 40.00
- IMRX 24.02
About KZR Kezar Life Sciences Inc.
Kezar Life Sciences Inc is a clinical-stage biotechnology company. It is engaged in discovering and developing novel small molecule therapeutics to treat unmet needs in autoimmunity and cancer. The pipeline consist of product candidates such as Zetomipzomib (KZR-616), and KZR-261.
About IMRX Immuneering Corporation
Immuneering Corp is a biopharmaceutical company. It is focused on improving patient outcomes across a spectrum of debilitating oncologic and neurologic diseases by applying deep knowledge of translational bioinformatics to every stage of the drug development process. The company's proprietary computational Disease Cancelling Technology platform enables Immuneering's drug discovery programs. The company also provides unparalleled computational biology capabilities to pharmaceutical and biotechnology companies.